BLTE Stock Analysis: Buy, Sell, or Hold?
BLTE - Belite Bio, Inc American Depositary Shares
$156.90
-1.83 (-1.15%)
▼
5d:
-6.28%
30d:
+5.17%
90d:
-5.28%
HOLD
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 12, 2026
12d
Get Alerted When BLTE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BLTE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BLTE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$27.50
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$17.07
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLTE is currently trading at $156.90, which is considered slightly low relative to its 30-day fair value range of $154.91 to $172.31. The stock's valuation (Forward PE: 202.2) is in line with its historical norms (202.9). Remarkably, the market is currently pricing in an annual earnings decline of 0.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BLTE is in a uptrend. The price is currently testing key support at $153.69. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BLTE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $211.50 (+33.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BLTE is in a uptrend. The price is currently testing key support at $153.69. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BLTE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $211.50 (+33.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$154.91 -
$172.31
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 33.2% below Wall St target ($211.50)
- CAUTION: 5-day price weakness (-6.3%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$154.91 -
$172.31
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$153.69
Resistance Level
$173.30
Current Trend
Uptrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
202.20
Wall Street Target
$211.50
(+33.2%)
Valuation Discount vs History
-0.1% cheaper
PE vs Historical
202.2 vs 202.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.1%
(market-implied from PE analysis)
1-Year Target
$158.57
(0%)
2-Year Target
$158.41
(0%)
3-Year Target
$158.25
(0%)
3-Yr Target (if PE normalizes)
(PE: 202→203)
$158.80
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 202.2 to 202.9
Stabilization Target:
$159.28
(+0.3%)
PE Expansion Potential:
+0.3%
Share & Embed Analysis
Last updated: April 29, 2026 10:52 AM ET
Data refreshes hourly during market hours. Next update: 11:52 AM
Data refreshes hourly during market hours. Next update: 11:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLTE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Nathan L Mata
SELL
1000 shares
2026-04-20
Nathan L Mata
SELL
1000 shares
2026-04-17
Nathan L Mata
SELL
1000 shares
2026-04-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$408 | 52 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$27 | 57 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$131 | 55 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 53 HOLD |
